(Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for ...

As the anti-involution policy continued to advance, the second round of coke price hikes was officially implemented. This, combined with persistently tight spot supply and demand, capacity constraints ...

Overnight, the overseas market mostly rose, with only LME copper and LME zinc falling together. LME copper fell 0.78% and LME zinc fell 0.44%. LME nickel led the gains at 1.39%, LME tin rose 0.92%, ...

A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Li, Chief Executive Officer at ...

Xinhua Commentary: Platforms Must Not Only Profit but Also Act as Gatekeepers in Crackdown on "Ghost Takeaways" ...

Beijing is no longer content to watch China’s solar manufacturers destroy each other. In May 2026, the Ministry of Industry ...

Two studies published in Nature used artificial intelligence to measure the health of the human thymus from routine chest CT scans, finding that people with healthier thymus tissue lived longer and ...

In stripping away the very core of technology, contemporary Italian artist Leonardo Ulian creates unique maze-like ...

China's state-of-the-art factories reflect its commitment to innovation, backed by robust research and development ...

China's market regulator on Monday unveiled measures to tackle "involution-style" competition across the platform economy and key new‑energy sectors, as part of greater efforts to advance a fair, high ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...